Sort
21,453 grants matching “tuberculosis”
HUMAN T CELLS ANTIGENS OF MYCOBACTERIUM TUBERCULOSIS
$378,081Infectious Disease Research Institute · R01 · FY2003 · AI
Defining age-associated immune correlates of susceptibility to M. tuberculosis
$378,075Joanne Turner · Texas Biomedical Research Institute · P01 · FY2020 · AG
T regulatory cells and immunity in tuberculosis
$378,074Kevin B Urdahl · Seattle Children'S Hospital · R01 · FY2018 · AI
Structural Studies of Enzymes of Thiamin Biosynthesis
$378,065Steven E Ealick · Cornell University · R01 · FY2010 · DK
Development of Selective Ribosomal P-site Inhibitors
$378,021Ryan Edward Looper · University Of Utah · R01 · FY2017 · AI
Highly Sensitive HIV Viral Load Assay for Point-of-Care Settings
$377,971Waseem Asghar · Florida Atlantic University · R56 · FY2019 · AI
Host Responses to Mycobacterium Infection in Zebrafish
$377,780Lalita Ramakrishnan · University Of Washington · R01 · FY2008 · AI
In vivo regulation of M. tuberculosis cell wall lipids
$377,686Lee W Riley · University Of California Berkeley · R01 · FY2010 · AI
A multi-disciplinary approach to the identification of host metabolic determinan
$377,662Megan Murray · Brigham And Women'S Hospital · U19 · FY2017 · AI
Host Responses to Mycobacterium Infection in Zebrafish
$377,636Lalita Ramakrishnan · University Of Washington · R01 · FY2009 · AI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis
$377,631Harvey Rubin · University Of Pennsylvania · R01 · FY2011 · AI
Generation and persistence of CD4 memory subsets
$377,615Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio
$377,585Paul Timothy Elkington · University Of Southampton · R33 · FY2015 · AI
Understanding and manipulating chronic Helicobacter pylori to enhance treatment
$377,553Karen M Ottemann · University Of California Santa Cruz · R01 · FY2022 · AI
Understanding and manipulating chronic Helicobacter pylori to enhance treatment
$377,553Karen M Ottemann · University Of California Santa Cruz · R01 · FY2023 · AI
Understanding and manipulating chronic Helicobacter pylori to enhance treatment
$377,553Karen M Ottemann · University Of California Santa Cruz · R01 · FY2024 · AI
Understanding and manipulating chronic Helicobacter pylori to enhance treatment
$377,553Karen M Ottemann · University Of California Santa Cruz · R01 · FY2025 · AI
Understanding and manipulating chronic Helicobacter pylori to enhance treatment
$377,553Karen M Ottemann · University Of California Santa Cruz · R01 · FY2021 · AI
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis
$377,500Sangeeta Tiwari · University Of Texas El Paso · SC1 · FY2024 · GM
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis
$377,500Sangeeta Tiwari · University Of Texas El Paso · SC1 · FY2023 · GM
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis
$377,500Sangeeta Tiwari · University Of Texas El Paso · SC1 · FY2021 · GM
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis
$377,500Sangeeta Tiwari · University Of Texas El Paso · SC1 · FY2022 · GM
Role of Vitamin D Prohormone 25-OHD in the Immune Response to Tuberculosis
$377,443Robert L Modlin · University Of California Los Angeles · R01 · FY2015 · HL
Group 1 CD1 in Infectious Disease and T Cell Development
$377,438Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2012 · AI
Group 1 CD1 in Infectious Disease and T Cell Development
$377,438Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2011 · AI